Unit
- Feasibility assessment: A systematic evaluation process that determines whether a proposed healthcare project is viable before significant resources are committed. It integrates financial, operational, regulatory, and market analyses to support informed decision-making.
- Healthcare context: Unlike other industries, healthcare feasibility must account for patient safety, regulatory mandates, and ethical obligations. A service that is financially viable but compromises quality of care is not truly feasible.
- Common triggers: Feasibility studies are initiated when organizations consider new clinics, equipment acquisitions, service line expansions, technology implementations, or partnerships. Each trigger requires tailored assessment criteria.
- Key stakeholders: The process involves administrators, clinical leaders, finance officers, legal counsel, community representatives, and regulators. Their input shapes the scope and criteria of the study.
- Outcome types: Results may recommend full adoption, conditional adoption with modifications, postponement, or rejection. Each recommendation is backed by evidence from the analysis.
- Relationship to business planning: Feasibility assessment precedes business planning. It answers whether an idea is worth planning further, while business planning details how to execute a feasible concept.
- Common pitfalls: These include confirmation bias, incomplete data, ignoring intangibles like staff morale, and failing to update old studies for current conditions. Awareness helps avoid flawed conclusions.
- Ethical dimension: Feasibility must consider equitable access, community impact, and alignment with the organization's mission. A profitable project that widens health disparities may be ethically infeasible.
- Timeline and phasing: A typical feasibility study spans 4 to 12 weeks, depending on complexity. Phases include scoping, data gathering, analysis, stakeholder review, and final reporting. Adequate time for data validation and iterative feedback prevents premature conclusions.
- Risk analysis integration: Feasibility assessment should identify and classify risks across clinical, financial, regulatory, and reputational domains. A risk matrix helps prioritize mitigation strategies. Projects with high unmitigable risks may be deemed infeasible regardless of projected returns.
- Data sources and validation: Reliable feasibility relies on primary data from interviews and surveys as well as secondary data from benchmarking reports, census figures, and financial records. Cross-verifying data from multiple sources strengthens credibility and reduces the chance of biased or outdated figures.
- Iterative refinement: Feasibility is not a one-time pass or fail. Early findings may prompt adjustments to scope, assumptions, or options. Revisiting criteria after initial analysis allows the team to refine recommendations and propose conditional adoption with specific performance targets.
Scope of Practice
Role: Healthcare Project Manager
Within scope:
- Initiating and scoping feasibility studies based on organizational priorities
- Coordinating data collection from clinical, financial, and operational departments
- Engaging stakeholders through interviews and focus groups
- Synthesizing findings into a feasibility report with recommendations
- Presenting results to executive leadership and board committees
Outside scope:
- Making final go/no-go decisions, which belong to organizational governance
- Certifying financial projections without validation from accounting professionals
- Providing clinical judgment on medical necessity or patient outcomes
- Overriding regulatory requirements or legal constraints
- Committing organizational funds without authorized approval
Quick Revision
- Feasibility assessment evaluates viability across financial, operational, regulatory, and market dimensions.
- Healthcare feasibility extends beyond profit to include patient safety and ethical considerations.
- Stakeholder engagement is critical to defining study scope and criteria.
- The project manager coordinates but does not unilaterally decide feasibility outcomes.